Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Tax Provisions (2020 - 2025)

Puma Biotechnology (PBYI) has disclosed Tax Provisions for 6 consecutive years, with $293000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Tax Provisions rose 33.18% year-over-year to $293000.0, compared with a TTM value of $73000.0 through Mar 2025, down 93.69%, and an annual FY2023 reading of $1.1 million, up 198.35% over the prior year.
  • Tax Provisions was $293000.0 for Q1 2025 at Puma Biotechnology, up from -$889000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $536000.0 in Q4 2023 and bottomed at -$889000.0 in Q4 2024.
  • Average Tax Provisions over 5 years is $126214.3, with a median of $199500.0 recorded in 2021.
  • The sharpest move saw Tax Provisions soared 217.91% in 2023, then crashed 265.86% in 2024.
  • Year by year, Tax Provisions stood at $212000.0 in 2021, then crashed by 68.4% to $67000.0 in 2022, then soared by 700.0% to $536000.0 in 2023, then plummeted by 265.86% to -$889000.0 in 2024, then soared by 132.96% to $293000.0 in 2025.
  • Business Quant data shows Tax Provisions for PBYI at $293000.0 in Q1 2025, -$889000.0 in Q4 2024, and $291000.0 in Q3 2024.